The World Health Organization (WHO) has praised Saudi Arabia for its outstanding hospital quality and effective infection control measures. The Kingdom emerges as a global leader, showcasing success in reducing healthcare-associated risks across its health facilities.
In a report on its official website, WHO highlighted Saudi Arabia’s significant achievement in reducing central line-associated bloodstream infections (CLABSI) by a staggering 48.8% annually from 2021 to 2024. This impressive figure surpasses the global average by a factor of four.
National Strategy Drives Infection Control Success
From 2021 to 2024, Saudi Arabia reduced CLABSI rates in intensive care units by 48.8% annually. This achievement surpasses the global reduction average by fourfold during the same period.
This progress stems from the national strategy launched by the Ministry of Health in 2022 to combat bloodstream infections. The initiative aligns with broader efforts to improve infection control across health facilities and elevate healthcare service quality.
Vision 2030 Fuels Transformative Healthcare Reforms
The Ministry of Health trained over 5,000 healthcare practitioners nationwide in infection control practices as part of this program. These efforts reflect Saudi Vision 2030’s goal of transforming healthcare by prioritizing prevention and ensuring top-tier patient care.
Saudi health facilities have implemented stringent infection control measures, significantly improving patient safety and minimizing infection risks in healthcare settings.
WHO also noted that Saudi Arabia’s initiatives have reduced other healthcare-associated infections, enhancing the quality and safety of medical services across the Kingdom.
